Displaid

Displaid is a biotechnology startup based in Canada that aims to assist people with renal and cardiac insufficiency. With the slogan "Une startup en biotechnologies qui veut aider les gens atteint d'insuffisance rénale et cardiaque," the company's mission is to help patients with chronic diseases regain control. Founded in 2021, Displaid offers a solution that allows patients to access medical imaging technology at home, thereby reducing the risk of hospitalization and enhancing their quality of life. The startup received a $20.00K grant investment on 27 April 2023 from The Bourse+. The company operates in the health care industry, addressing an increasingly important and relevant area in the healthcare sector. Displaid's innovative approach has the potential to make a significant impact on the lives of individuals with chronic diseases.